Nippon Kayaku Co (4272) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
19 Aug, 2025Executive summary
Net sales for FY 2025 3Q rose 12.2% year-over-year to ¥168.0 billion, driven by strong Mobility & Imaging and Fine Chemicals, while Life Science slightly declined.
Operating income surged 147.2% to ¥24.8 billion, with all business units contributing to the increase.
Profit attributable to owners of parent jumped 370.5% to ¥13.3 billion.
Ordinary income increased 181.1% to ¥21.0 billion.
Financial highlights
Gross profit margin improved to 32.3% from 30.3% year-over-year.
Operating income margin increased to 10.8% from 2.7% year-over-year.
ROE rose to 6.6%, up 5.0 percentage points from the previous year.
Equity ratio stood at 71.7%, down 2.5 percentage points.
Total assets increased to ¥378.0 billion as of December 31, 2024.
Outlook and guidance
Full-year net sales forecast raised to ¥223.7 billion, up ¥3.4 billion from previous guidance.
Operating income forecast increased to ¥30.3 billion, up ¥1.8 billion.
Profit attributable to owners of parent forecast at ¥17.9 billion, up ¥2.6 billion.
Dividend per share for FY 2025 increased to ¥60, with a total payout ratio of 109.9%.
Latest events from Nippon Kayaku Co
- Profit attributable to owners of parent rose 30.1% on 4.0% sales growth, outlook steady.4272
Q3 20262 Feb 2026 - Net sales up 4.1% and profit nearly doubled on investment gains despite cost pressures.4272
Q2 202612 Nov 2025 - Strong sales and profit growth driven by Mobility & Imaging and Fine Chemicals; outlook revised up.4272
Q1 202519 Aug 2025 - Sales and operating income surged, with upward guidance and major treasury stock buybacks.4272
Q2 202519 Aug 2025 - Record profit and strong segment growth; FY 2026 sees sales up, profit slightly down.4272
Q4 202519 Aug 2025 - Sales rose but profits fell amid higher costs and global risks; outlook remains cautious.4272
Q1 202619 Aug 2025